ar-l 57 cl has been researched along with sulmazole in 2 studies
| Studies (ar-l 57 cl) | Trials (ar-l 57 cl) | Recent Studies (post-2010) (ar-l 57 cl) | Studies (sulmazole) | Trials (sulmazole) | Recent Studies (post-2010) (sulmazole) |
|---|---|---|---|---|---|
| 12 | 1 | 0 | 213 | 5 | 7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayes, JS; Kauffman, RF; Robertson, DW; Wilson, HC; Wyss, VL | 1 |
| Diederen, W; Kadatz, R | 1 |
2 other study(ies) available for ar-l 57 cl and sulmazole
| Article | Year |
|---|---|
Molecular basis for the in vitro and in vivo cardiotonic activities of AR-L100.
Topics: Animals; Carbachol; Cats; Cyclic AMP; Dogs; Dose-Response Relationship, Drug; Female; Heart; Imidazoles; Isoproterenol; Male; Myocardial Contraction; Ouabain; Phosphodiesterase Inhibitors; Rubidium; Sodium-Potassium-Exchanging ATPase; Structure-Activity Relationship | 1986 |
Comparative cardiovascular effects of three benzimidazole derivatives, AR-L 57 BS, AR-L 100 BS, and AR-L 115 BS.
Topics: Administration, Oral; Animals; Cardiotonic Agents; Cats; Dogs; Female; Heart; Hemodynamics; Imidazoles; In Vitro Techniques; Injections, Intravenous; Lethal Dose 50; Male; Mice; Myocardial Contraction; Rats; Species Specificity | 1981 |